Cancer vaccines could allow the priming and intratumoral recruitment of CD8+ T cells and transform a “non-inflamed” non-permissive tumor resistant to checkpoint blockade into a sensitive “inflamed” tumor [39]. The gene discussed is CD8A; the disease is cancer.